LHCOX
Price
$18.52
Change
+$0.04 (+0.22%)
Updated
Jun 6 closing price
Net Assets
7.33M
SHSAX
Price
$61.20
Change
+$0.43 (+0.71%)
Updated
Jun 6 closing price
Net Assets
6.46B
Interact to see
Advertisement

LHCOX vs SHSAX

Header iconLHCOX vs SHSAX Comparison
Open Charts LHCOX vs SHSAXBanner chart's image
Lord Abbett Health Care F3
Price$18.52
Change+$0.04 (+0.22%)
VolumeN/A
Net Assets7.33M
BlackRock Health Sciences Opps Inv A
Price$61.20
Change+$0.43 (+0.71%)
VolumeN/A
Net Assets6.46B
LHCOX vs SHSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LHCOX vs. SHSAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LHCOX is a Buy and SHSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 6.46B vs. LHCOX (7.33M). LHCOX pays higher dividends than SHSAX: LHCOX (0.61) vs SHSAX (0.23). LHCOX was incepted earlier than SHSAX: LHCOX (6 years) vs SHSAX (25 years). LHCOX (2.99) is less costly to investors than SHSAX (1.09). LHCOX is a more actively managed with annual turnover of: 88.00 vs. SHSAX (27.00). LHCOX has a lower initial minimum investment than SHSAX: LHCOX (0) vs SHSAX (1000). LHCOX annual gain was more profitable for investors over the last year : -5.26 vs. SHSAX (-14.66). LHCOX return over 5 years is better than : 7.64 vs. SHSAX (-9.04).
LHCOXSHSAXLHCOX / SHSAX
Total Expense Ratio0.681.0962%
Annual Report Gross Expense Ratio2.991.09274%
Fund Existence6 years25 years-
Gain YTD-4.840-2.675181%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.33M6.46B0%
Annual Yield % from dividends0.610.23267%
Returns for 1 year-5.26-14.6636%
Returns for 3 years9.74-9.26-105%
Returns for 5 years7.64-9.04-85%
Returns for 10 yearsN/A11.41-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDNRX71.38N/A
N/A
Janus Henderson Growth And Income R
PGRUX9.56N/A
N/A
Principal Global Real Estate Sec R5
TEMUX14.87N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
SCIUX11.18N/A
N/A
Invesco Income Advantage U.S. Fund R5
GEBRX10.73N/A
N/A
Goldman Sachs ESG Em Mkts Eq R